DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited
DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations
DSS Launches New Business, DSS Robotics, Focused On AI-Powered Robotics And Intelligent Automation Solutions For Enterprise Customers
DSS Shares Crash After Soaring. What the New Offering Means for Investors
DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering
DSS Plans Not To Proceed With Previously Announced Common Stock Offering
DSS Plans New Share Sale To Boost Working Capital
DSS, Inc. Announces Launch of Proposed Public Offering
DSS, Inc. Withdraws Registration Statement
DSS Withdraws S-1 Registration Statement; No Securities Were Sold In Connection With The Transactions Contemplated By The Registration Statement.
DSS Q1 EPS $(0.60) Misses $(0.38) Estimate, Sales $4.331M Miss $5.100M Estimate
DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing
DSS Announces Going Concern Warning Included In 2025 Annual Report
DSS, Inc. Letter to Shareholders
DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering
DSS Commences ~$1M Offering Of 900K Common shares At $1/Share
DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering
DSS, Inc. Prices $1M Underwritten Public Offering Of 900,000 Common Shares At $1.00 Each
Reported Earlier, DSS Proposes Public Offering Of Common Stock, Proceeds To Support General Corporate And Working Capital Needs
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.